Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Other Non-Current Liabilities (2020 - 2023)

Historic Other Non-Current Liabilities for Journey Medical (DERM) over the last 4 years, with Q2 2023 value amounting to $1.5 million.

  • Journey Medical's Other Non-Current Liabilities fell 6087.18% to $1.5 million in Q2 2023 from the same period last year, while for Jun 2023 it was $1.5 million, marking a year-over-year decrease of 6087.18%. This contributed to the annual value of $1.4 million for FY2022, which is 6106.98% down from last year.
  • Per Journey Medical's latest filing, its Other Non-Current Liabilities stood at $1.5 million for Q2 2023, which was down 6087.18% from $1.4 million recorded in Q1 2023.
  • Journey Medical's 5-year Other Non-Current Liabilities high stood at $8.1 million for Q4 2020, and its period low was $1.4 million during Q3 2022.
  • Its 4-year average for Other Non-Current Liabilities is $3.3 million, with a median of $3.6 million in 2021.
  • In the last 5 years, Journey Medical's Other Non-Current Liabilities tumbled by 5542.58% in 2021 and then crashed by 6852.23% in 2022.
  • Journey Medical's Other Non-Current Liabilities (Quarter) stood at $8.1 million in 2020, then crashed by 55.43% to $3.6 million in 2021, then tumbled by 61.07% to $1.4 million in 2022, then grew by 5.52% to $1.5 million in 2023.
  • Its Other Non-Current Liabilities stands at $1.5 million for Q2 2023, versus $1.4 million for Q1 2023 and $1.4 million for Q4 2022.